195 related articles for article (PubMed ID: 38266642)
21. A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine.
Ambrosino P; Ragona F; Mosca I; Vannicola C; Canafoglia L; Solazzi R; Rivolta I; Freri E; Granata T; Messina G; Castellotti B; Gellera C; Soldovieri MV; DiFrancesco JC; Taglialatela M
Epilepsia; 2023 Jul; 64(7):e148-e155. PubMed ID: 37203213
[TBL] [Abstract][Full Text] [Related]
22. Myoclonus improvement after seizures in progressive myoclonic epilepsy type 7: a case report.
G S B Lima PL; Nobrega PR; Freua F; Braga-Neto P; Paiva ARB; Guimarães TG; Kok F
BMC Neurol; 2024 May; 24(1):169. PubMed ID: 38783211
[TBL] [Abstract][Full Text] [Related]
23. Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K
Oliver KL; Franceschetti S; Milligan CJ; Muona M; Mandelstam SA; Canafoglia L; Boguszewska-Chachulska AM; Korczyn AD; Bisulli F; Di Bonaventura C; Ragona F; Michelucci R; Ben-Zeev B; Straussberg R; Panzica F; Massano J; Friedman D; Crespel A; Engelsen BA; Andermann F; Andermann E; Spodar K; Lasek-Bal A; Riguzzi P; Pasini E; Tinuper P; Licchetta L; Gardella E; Lindenau M; Wulf A; Møller RS; Benninger F; Afawi Z; Rubboli G; Reid CA; Maljevic S; Lerche H; Lehesjoki AE; Petrou S; Berkovic SF
Ann Neurol; 2017 May; 81(5):677-689. PubMed ID: 28380698
[TBL] [Abstract][Full Text] [Related]
24. Age-Dependent Reduction in the Expression Levels of Genes Involved in Progressive Myoclonus Epilepsy Correlates with Increased Neuroinflammation and Seizure Susceptibility in Mouse Models.
Sinha P; Verma B; Ganesh S
Mol Neurobiol; 2022 Sep; 59(9):5532-5548. PubMed ID: 35732865
[TBL] [Abstract][Full Text] [Related]
25. Function of specific K(+) channels in sustained high-frequency firing of fast-spiking neocortical interneurons.
Erisir A; Lau D; Rudy B; Leonard CS
J Neurophysiol; 1999 Nov; 82(5):2476-89. PubMed ID: 10561420
[TBL] [Abstract][Full Text] [Related]
26. The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia.
Kaar SJ; Angelescu I; Nour MM; Marques TR; Sharman A; Sajjala A; Hutchison J; McGuire P; Large C; Howes OD
Psychopharmacology (Berl); 2022 Oct; 239(10):3313-3323. PubMed ID: 36094619
[TBL] [Abstract][Full Text] [Related]
27. Interneuron Desynchronization Precedes Seizures in a Mouse Model of Dravet Syndrome.
Tran CH; Vaiana M; Nakuci J; Somarowthu A; Goff KM; Goldstein N; Murthy P; Muldoon SF; Goldberg EM
J Neurosci; 2020 Mar; 40(13):2764-2775. PubMed ID: 32102923
[TBL] [Abstract][Full Text] [Related]
28. Conventional and novel anti-seizure medications reveal a particular role for GABA
Polet SS; de Koning TJ; Lambrechts RA; Tijssen MAJ; Sibon OCM; Gorter JA
Epilepsy Res; 2024 Jul; 203():107380. PubMed ID: 38781737
[TBL] [Abstract][Full Text] [Related]
29. Distribution of Kv3.3 potassium channel subunits in distinct neuronal populations of mouse brain.
Chang SY; Zagha E; Kwon ES; Ozaita A; Bobik M; Martone ME; Ellisman MH; Heintz N; Rudy B
J Comp Neurol; 2007 Jun; 502(6):953-72. PubMed ID: 17444489
[TBL] [Abstract][Full Text] [Related]
30. Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic Dysfunction.
Kaar SJ; Nottage JF; Angelescu I; Marques TR; Howes OD
Clin EEG Neurosci; 2024 Mar; 55(2):203-213. PubMed ID: 36591873
[TBL] [Abstract][Full Text] [Related]
31. A Novel Modulator of Kv3 Potassium Channels Regulates the Firing of Parvalbumin-Positive Cortical Interneurons.
Rosato-Siri MD; Zambello E; Mutinelli C; Garbati N; Benedetti R; Aldegheri L; Graziani F; Virginio C; Alvaro G; Large CH
J Pharmacol Exp Ther; 2015 Sep; 354(3):251-60. PubMed ID: 26085652
[TBL] [Abstract][Full Text] [Related]
32. Motor dysfunction and altered synaptic transmission at the parallel fiber-Purkinje cell synapse in mice lacking potassium channels Kv3.1 and Kv3.3.
Matsukawa H; Wolf AM; Matsushita S; Joho RH; Knöpfel T
J Neurosci; 2003 Aug; 23(20):7677-84. PubMed ID: 12930807
[TBL] [Abstract][Full Text] [Related]
33. Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3.
Espinosa F; McMahon A; Chan E; Wang S; Ho CS; Heintz N; Joho RH
J Neurosci; 2001 Sep; 21(17):6657-65. PubMed ID: 11517255
[TBL] [Abstract][Full Text] [Related]
34. Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
Irie T; Matsuzaki Y; Sekino Y; Hirai H
J Physiol; 2014 Jan; 592(1):229-47. PubMed ID: 24218544
[TBL] [Abstract][Full Text] [Related]
35. A structurally precise mechanism links an epilepsy-associated
Clatot J; Currin CB; Liang Q; Pipatpolkai T; Massey SL; Helbig I; Delemotte L; Vogels TP; Covarrubias M; Goldberg EM
Proc Natl Acad Sci U S A; 2024 Jan; 121(3):e2307776121. PubMed ID: 38194456
[TBL] [Abstract][Full Text] [Related]
36. Subcellular localization of the K+ channel subunit Kv3.1b in selected rat CNS neurons.
Sekirnjak C; Martone ME; Weiser M; Deerinck T; Bueno E; Rudy B; Ellisman M
Brain Res; 1997 Aug; 766(1-2):173-87. PubMed ID: 9359601
[TBL] [Abstract][Full Text] [Related]
37. Increased gamma- and decreased delta-oscillations in a mouse deficient for a potassium channel expressed in fast-spiking interneurons.
Joho RH; Ho CS; Marks GA
J Neurophysiol; 1999 Oct; 82(4):1855-64. PubMed ID: 10515974
[TBL] [Abstract][Full Text] [Related]
38. A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.
Bassuk AG; Wallace RH; Buhr A; Buller AR; Afawi Z; Shimojo M; Miyata S; Chen S; Gonzalez-Alegre P; Griesbach HL; Wu S; Nashelsky M; Vladar EK; Antic D; Ferguson PJ; Cirak S; Voit T; Scott MP; Axelrod JD; Gurnett C; Daoud AS; Kivity S; Neufeld MY; Mazarib A; Straussberg R; Walid S; Korczyn AD; Slusarski DC; Berkovic SF; El-Shanti HI
Am J Hum Genet; 2008 Nov; 83(5):572-81. PubMed ID: 18976727
[TBL] [Abstract][Full Text] [Related]
39. Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3.
McMahon A; Fowler SC; Perney TM; Akemann W; Knöpfel T; Joho RH
Eur J Neurosci; 2004 Jun; 19(12):3317-27. PubMed ID: 15217387
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological modulation of Kv3 voltage-gated potassium channels regulates fear discrimination and expression in a response-dependent manner.
Stubbendorff C; Hale E; Day HLL; Smith J; Alvaro GS; Large CH; Stevenson CW
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110829. PubMed ID: 37451593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
